Rietiker Tightens Belt At Sulzer Medica By Cutting Staff, Consolidating
This article was originally published in The Gray Sheet
Executive Summary
Sulzer IntraTherapeutics, a unit within Sulzer Medica's Cardiovascular Division, will cut 21% of its staff as part of a company-wide effort to cut costs and improve operating efficiency, the company announced Oct 23.